Cupid Ltd. (BSE: 530843) is a Nashik, Maharashtra-based company in the Sexual Wellness Products industry. With a market capitalisation of ₹41,214 Cr, it ranks #220 by market cap among the 6,189 Indian listed companies on FinBizNet, and #1 of 3 in Sexual Wellness Products. At ₹306.50 (as of 26 Oct 2026), the share price is 16.9% below its 52-week high of ₹368.95 and 556.0% above its 52-week low of ₹46.72. The share price is up 503.6% over one year and up 43.6% over three months.
| Current Price | ₹306.50 |
|---|---|
| Market Cap | ₹41,214 Cr |
| BSE Code | 530843 |
| Sector | Consumer Staples > Household and Personal Products > Personal Care Products |
| Sub-Industry | Personal Care Products > Sexual Wellness Products |
| P/E Ratio | 388 |
| Return on Equity | 27.30% |
| Return on Assets | 15.12% |
| 52-Week Range | ₹46.72 – ₹368.95 |
| 1-Year Price Change | +503.6% |
| 3-Month Price Change | +43.6% |
| Beta (1Y) | 0.47 |
| Dividend Yield | 0.00% |
| Headquarters | Nashik, Maharashtra |
| Website | www.cupidlimited.com |
| Revenue | ₹155 Cr |
|---|---|
| Net Profit | ₹44 Cr |
| Net Margin | 28.5% |
| EPS (Basic) | ₹0.33 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Cupid Limited designs, manufactures, markets, and exports male and female condoms in India. The company offers water based lubricant jellies; in vitro diagnostic kits, including rapid diagnostic, viral transport medium, typhoid antibody, syphilis antibody, HIV 1 and 2 kit antibody, dengue IgG/IgM, malaria Pf-Pv and Pf-PAN antigen, hepatitis B (HbsAg) antigen, hepatitis C (HCV) antibody, pregnancy detection testing kit, LH ovulation testing kit, and dengue NS1 testing kit; and personal care products including deodorants, perfumes, toilet sanitizers, menstrual cups, petroleum jelly, hair and body oils, and hair removal sprays. It also exports its products to countries in Africa, Europe, Asia-Pacific, North America, Middle East, and South America. The company was formerly known as Cupid Condom Limited and changed its name to Cupid Limited in January 2006. The company was incorporated in 1993 and is based in Nashik, India.
1. Female Condoms-0 2. Jelly-0 3. In Vitro Devices (IVD)-0 4. Male and Female Contraceptives & Jelly-This segment designs and manufactures male and female condoms, and lubricant jellies.
1. Personal Care-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Cupid Ltd. | ₹41,214 Cr | 388 | 27.30% | ₹155 Cr | +503.6% |
| TTK Healthcare Ltd. | ₹1,336 Cr | 20.3 | 6.03% | ₹258 Cr | -15.9% |
| Rajnish Wellness Ltd | ₹35 Cr | -5.7 | -6.73% | — | -61.4% |
Listed by market capitalisation. Ratios are shown for context only.
Cupid Ltd. is trading at ₹306.50, with a market capitalisation of ₹41,214 Cr.
Cupid Ltd. operates in the Consumer Staples > Household and Personal Products > Personal Care Products space (Personal Care Products > Sexual Wellness Products).
Cupid Ltd. has a P/E of 388 and a return on equity of 27.30%.
Cupid Ltd. is listed on the BSE under the scrip code 530843.
Cupid Ltd.'s share price is up 503.6% over one year and up 43.6% over three months. Its 52-week range is ₹46.72 to ₹368.95.
In Q1 FY27, Cupid Ltd. reported revenue of ₹155 Cr and net profit of ₹44 Cr, with basic EPS of ₹0.33 (consolidated, parsed from the company's exchange filing).
Data as of 26 Oct 2026. Descriptive market data only — not investment advice.